person · Reporting owner
Min Kwan-Hong Christopher
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Longeveron Inc.LGVN · Entity 7608 | Chief Medical Officer | April 04, 2022 | April 12, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Longeveron Inc.
Report date April 04, 2022 · Filed April 12, 2022 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,335 |
Reported balance
After 2022-04-04 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2022-04-04 · Grant · Acquired 2,335 · Balance 2,335 F1: Represents the award of 2,335 Restricted Stock Units, which vested 50% on April 4, 2022, with the remaining 50% to vest on January 1, 2023. F2: Includes 2,335 Restricted Stock Units. |
| Common StockSEC Table I · non-derivative | Direct | 1,978 |
Reported balance
After 2022-04-04 transaction · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · 2022-04-04 · Tax withholding · Disposed 357 · Balance 1,978 F3: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the Restricted Stock Units and does not represent a sale. This Form 4 amendment is being filed solely to report this withholding, which was not reflected in the original Form 4 filed on April 6, 2022. |
| Common StockSEC Table I · non-derivative | Direct | 151,978 |
Reported balance
After 2022-04-04 transaction · row 3
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 3 · 2022-04-04 · Grant · Acquired 150,000 · Balance 151,978 F4: Represents the award of 150,000 Restricted Stock Units, which vest ratably 25% each year. F5: Includes 151,978 Restricted Stock Units. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.85 · Expires 2032-04-03 | Direct | 2,335 |
Reported balance
After 2022-04-04 transaction · row 4
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 4 · 2022-04-04 · Grant · Acquired 2,335 · Balance 2,335 F6: The option vested 50% on April 4, 2022, with the remaining 50% to vest on January 1, 2023. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.85 · Expires 2032-04-03 | Direct | 50,000 |
Reported balance
After 2022-04-04 transaction · row 5
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 5 · 2022-04-04 · Grant · Acquired 150,000 · Balance 50,000 F7: The option vests ratably 25% each year. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the award of 2,335 Restricted Stock Units, which vested 50% on April 4, 2022, with the remaining 50% to vest on January 1, 2023.
F2: Includes 2,335 Restricted Stock Units.
F3: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the Restricted Stock Units and does not represent a sale. This Form 4 amendment is being filed solely to report this withholding, which was not reflected in the original Form 4 filed on April 6, 2022.
F4: Represents the award of 150,000 Restricted Stock Units, which vest ratably 25% each year.
F5: Includes 151,978 Restricted Stock Units.
F6: The option vested 50% on April 4, 2022, with the remaining 50% to vest on January 1, 2023.
F7: The option vests ratably 25% each year.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 04, 2022 Filed Apr 6, 2022 21:15 UTC | Longeveron Inc. LGVN · Entity 7608 | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $12.85 | $0.00 |
DisclosureSEC source: 0001214659-22-004906 · marketforms-55973.xml · derivative · entry 4 Min Kwan-Hong Christopher · CIK 0001921798 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common stock · 50,000 shares Expires 2032-04-03 F6 · derivative.exercise_date: The option vests ratably 25% each year. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 21:15 UTC | Longeveron Inc. LGVN · Entity 7608 | GrantStock Option (right to buy) · Derivative | 2,335 | $0.00 Strike: $12.85 | $0.00 |
DisclosureSEC source: 0001214659-22-004906 · marketforms-55973.xml · derivative · entry 3 Min Kwan-Hong Christopher · CIK 0001921798 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,335 Underlying: Common stock · 2,335 shares Expires 2032-04-03 F5 · derivative.exercise_date: The option vested 50% on April 4, 2022, with the remaining 50% to vest on January 1, 2023. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 21:15 UTC | Longeveron Inc. LGVN · Entity 7608 | GrantCommon stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-004906 · marketforms-55973.xml · nonDerivative · entry 2 Min Kwan-Hong Christopher · CIK 0001921798 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,335 F3 · shares: Represents the award of 150,000 Restricted Stock Units, which vest ratably 25% each year. F4 · balance_after: Includes 152,335 Restricted Stock Units. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 21:15 UTC | Longeveron Inc. LGVN · Entity 7608 | GrantCommon stock | 2,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-004906 · marketforms-55973.xml · nonDerivative · entry 1 Min Kwan-Hong Christopher · CIK 0001921798 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,335 F1 · shares: Represents the award of 2,335 Restricted Stock Units, which vested 50% on April 4, 2022, with the remaining 50% to vest on January 1, 2023. F2 · balance_after: Includes 2,335 Restricted Stock Units. Read SEC document |
| April 04, 2022 Filed Apr 12, 2022 21:38 UTC Amendment | Longeveron Inc. LGVN · Entity 7608 | GrantStock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $12.85 | $0.00 |
DisclosureSEC source: 0001214659-22-005165 · marketforms-55985.xml · derivative · entry 5 Min Kwan-Hong Christopher · CIK 0001921798 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-04-03 F7 · derivative.exercise_date: The option vests ratably 25% each year. Read SEC document |
| April 04, 2022 Filed Apr 12, 2022 21:38 UTC Amendment | Longeveron Inc. LGVN · Entity 7608 | GrantStock Option (right to buy) · Derivative | 2,335 | $0.00 Strike: $12.85 | $0.00 |
DisclosureSEC source: 0001214659-22-005165 · marketforms-55985.xml · derivative · entry 4 Min Kwan-Hong Christopher · CIK 0001921798 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,335 Underlying: Common Stock · 2,335 shares Expires 2032-04-03 F6 · derivative.exercise_date: The option vested 50% on April 4, 2022, with the remaining 50% to vest on January 1, 2023. Read SEC document |
| April 04, 2022 Filed Apr 12, 2022 21:38 UTC Amendment | Longeveron Inc. LGVN · Entity 7608 | GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-005165 · marketforms-55985.xml · nonDerivative · entry 3 Min Kwan-Hong Christopher · CIK 0001921798 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,978 F4 · shares: Represents the award of 150,000 Restricted Stock Units, which vest ratably 25% each year. F5 · balance_after: Includes 151,978 Restricted Stock Units. Read SEC document |
| April 04, 2022 Filed Apr 12, 2022 21:38 UTC Amendment | Longeveron Inc. LGVN · Entity 7608 | Tax withholdingCommon Stock | 357 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-005165 · marketforms-55985.xml · nonDerivative · entry 2 Min Kwan-Hong Christopher · CIK 0001921798 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,978 F3 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the Restricted Stock Units and does not represent a sale. This Form 4 amendment is being filed solely to report this withholding, which was not reflected in the original Form 4 filed on April 6, 2022. Read SEC document |
| April 04, 2022 Filed Apr 12, 2022 21:38 UTC Amendment | Longeveron Inc. LGVN · Entity 7608 | GrantCommon Stock | 2,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-005165 · marketforms-55985.xml · nonDerivative · entry 1 Min Kwan-Hong Christopher · CIK 0001921798 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,335 F1 · shares: Represents the award of 2,335 Restricted Stock Units, which vested 50% on April 4, 2022, with the remaining 50% to vest on January 1, 2023. F2 · balance_after: Includes 2,335 Restricted Stock Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.